These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38453400)

  • 1. [The role of the neuropsychologist in Parkinson's disease].
    Montillot J
    Soins; 2024 Mar; 69(883):42-45. PubMed ID: 38453400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep brain stimulation and the role of the neuropsychologist.
    Okun MS; Rodriguez RL; Mikos A; Miller K; Kellison I; Kirsch-Darrow L; Wint DP; Springer U; Fernandez HH; Foote KD; Crucian G; Bowers D
    Clin Neuropsychol; 2007 Jan; 21(1):162-89. PubMed ID: 17366283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical neuropsychology in Israel: history, training, practice and future challenges.
    Vakil E; Hoofien D
    Clin Neuropsychol; 2016 Nov; 30(8):1267-1277. PubMed ID: 27090578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and application of neuropsychology in Hong Kong: implications of its value and future advancement.
    Chan AS; Sze SL; Cheung MC; Han YM
    Clin Neuropsychol; 2016 Nov; 30(8):1236-1251. PubMed ID: 27684572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive screening in Parkinson's disease: Comparison of the Parkinson Neuropsychometric Dementia Assessment (PANDA) with 3 other short scales.
    Gasser AI; Calabrese P; Kalbe E; Kessler J; Rossier P
    Rev Neurol (Paris); 2016 Feb; 172(2):138-45. PubMed ID: 26494570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychology of Parkinson's disease.
    Toovey C; Anderson SW
    Prog Brain Res; 2022; 269(1):39-58. PubMed ID: 35248203
    [No Abstract]   [Full Text] [Related]  

  • 7. Cognitive impairment in Parkinson's disease is multifactorial: A neuropsychological study.
    Smith CR; Cullen B; Sheridan MP; Cavanagh J; Grosset KA; Grosset DG
    Acta Neurol Scand; 2020 Jun; 141(6):500-508. PubMed ID: 32002988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuropsychological characteristics of Parkinson's disease].
    Ostrosky-Solis F
    Rev Neurol; 2000 Apr 16-30; 30(8):788-96. PubMed ID: 10893746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Everyday functioning of people with Parkinson's disease and impairments in executive function: a qualitative investigation.
    Kudlicka A; Hindle JV; Spencer LE; Clare L
    Disabil Rehabil; 2018 Oct; 40(20):2351-2363. PubMed ID: 28597694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the cognitive and behavioral sequelae of Parkinson's disease: relationship to frontostriatal circuitry.
    Zgaljardic DJ; Borod JC; Foldi NS; Mattis P
    Cogn Behav Neurol; 2003 Dec; 16(4):193-210. PubMed ID: 14665819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Parkinson's disease: what gets in the way of the partnership relationship?].
    Pizani M
    Rev Infirm; 2015 Oct; (214):25-6. PubMed ID: 26455621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frontal deficits differentiate progressive supranuclear palsy from Parkinson's disease.
    Lee YE; Williams DR; Anderson JF
    J Neuropsychol; 2016 Mar; 10(1):1-14. PubMed ID: 25223526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The applause sign and neuropsychological profile in progressive supranuclear palsy and Parkinson's disease.
    Somme J; Gómez-Esteban JC; Tijero B; Berganzo K; Lezcano E; Zarranz JJ
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1230-3. PubMed ID: 23253819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychology Within a Tertiary Care Epilepsy Center.
    Morrison CE; MacAllister WS; Barr WB
    Arch Clin Neuropsychol; 2018 May; 33(3):354-364. PubMed ID: 29718083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuropsychology of Parkinson's disease.
    Taylor AE; Saint-Cyr JA
    Brain Cogn; 1995 Aug; 28(3):281-96. PubMed ID: 8546855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Description (reporting the actual words used in written letters) of the neuropsychological and psychopathological modifications produced by dopaminergic treatment in a young patient with Parkinson's disease.
    Cannas A; Solla P; Floris G; Tacconi P; Fulgheri P; Congia S; Spissu A
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):138-40. PubMed ID: 16033704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are non-demented patients with Parkinson's disease able to decide about their own treatment?
    Eygelshoven S; van den Hout A; Tucha L; Fuermaier ABM; Bangma DF; Thome J; Lobbestael J; Tucha O; Koerts J
    Parkinsonism Relat Disord; 2017 May; 38():48-53. PubMed ID: 28262511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Apathy in Parkinson's disease].
    García-Ramos R; Villanueva C; del Val J; Matías-Guíu J
    Neurologia; 2010; 25(1):40-50. PubMed ID: 20388460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia.
    Starkstein SE; Sabe L; Petracca G; Chemerinski E; Kuzis G; Merello M; Leiguarda R
    J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):381-7. PubMed ID: 8890777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychology in Finland - over 30 years of systematically trained clinical practice.
    Hokkanen L; Nybo T; Poutiainen E
    Clin Neuropsychol; 2016 Nov; 30(8):1214-1235. PubMed ID: 27684724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.